CorMedix (CRMD)
(Delayed Data from NSDQ)
$11.64 USD
-0.03 (-0.26%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $11.64 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
D Value C Growth F Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
CRMD 11.64 -0.03(-0.26%)
Will CRMD be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CRMD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CRMD
Hims & Hers Stock to Report Q2 Earnings: What's in the Cards?
CORT's Q2 Earnings Top Mark, Revenues Lag, '25 View Cut, Stock Down
CRMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
FOLD Q2 Earnings Miss Mark, Revenues Beat on Higher Product Sales
Does CorMedix (CRMD) Have the Potential to Rally 65.64% as Wall Street Analysts Expect?
Bausch Health Stock Falls on Q2 Earnings Miss, Revenues Beat
Other News for CRMD
March 2026 Options Now Available For CorMedix (CRMD)
This CorMedix Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Monday
CRMD Downgraded to Hold by D. Boral Capital | CRMD Stock News
Circle initiated, Disney upgraded: Wall Street's top analyst calls
CorMedix just downgraded at D. Boral Capital, here's why